Senvest Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Senvest Management’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-506,214	Closed	-$1.69M	–	71
2019 Q4	$1.69M	Sell	506,214 -249,784	-33%	-$794K	0.11%	36
2019 Q3	$2.3M	Hold	755,998	–	–	0.2%	34
2019 Q2	$1.8M	Hold	755,998	–	–	0.16%	34
2019 Q1	$2.83M	Hold	755,998	–	–	0.21%	41
2018 Q4	$2.71M	Buy	+755,998	New	+$3.29M	0.23%	38
2014 Q4	–	Sell	-70,000	Closed	-$382K	–	97
2014 Q3	$382K	Buy	+70,000	New	+$402K	0.04%	74

Senvest Management's FOMX Position: Q1 2020 in Review

Senvest Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 506,214 shares — an estimated $1.69M sold.

Senvest Management first reported a position in FOMX in Q3 2014 and held it in 6 quarters. The position peaked at $2.83M in Q1 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

Senvest Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
Senvest Management sold 506,214 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $1.69M.
Senvest Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2014 and held it in 6 quarters.
Senvest Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $2.83M in Q1 2019.
3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Senvest Management's 13F filing for Q1 2020, filed 14 May 2020.